Independent IRB niche Harrison IRB, LLC operates as an accredited, independent review board serving pharma, biotech, devices, diagnostics and CROs, indicating a potential upsell for broader IRB services and strategic partnerships with mid-market sponsors seeking compliant, impartial reviews.

Cost and efficiency focus The company emphasizes improving human research protection, site compliance and reducing IRB costs, suggesting opportunities to position premium services around cost optimization, streamlined workflows, and access to best practices and templates.

Smaller firm agility With 11-50 employees, Harrison IRB is a smaller firm compared to large incumbents, which may indicate openness to flexible pricing, rapid implementation projects, and personalized service levels for mid-sized sponsors and biotech clients.

Tech stack readiness Utilizes a mix of web and cloud technologies (Google Cloud, OpenResty, Nginx, Apache, DreamWeaver, jQuery), suggesting potential for offering modern digital submission portals, secure data handling, and integration services to streamline IRB workflows.

Revenue signals Reported revenue range of one to several million dollars positions Harrison IRB as a growth-ready target for expansion initiatives, strategic partnerships, and higher-value contracts with mid-market CROs and pharmaceutical sponsors seeking scalable IRB services.